| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 73573-87-2 | 福美特羅; 福莫特洛; N-[2-羥基-5-[1-羥基-2-[1-(4-甲氧基苯基)丙-2-基氨基]乙基]苯基]甲酰胺 | Formoterol; N-[2-Hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide |  | C19H24N2O4 | 詳情 | 供應商 |
| 70579-93-0 | Acetamide,N-[4-[2-hydroxy-3-[[2-(4-hydroxyphenyl)ethyl]amino]propoxy]phenyl]-; 4-hydroxyphenethylamino-3-(4-acetamido)phenoxypropan-2-ol |  | C19H24N2O4 | 詳情 | 供應商 | |
| 102009-04-1 | Acetamide,N-[4-[[5-(4-aminophenoxy)pentyl]oxy]phenyl]-2-hydroxy-; Glycolanilide,4'-[5-(p-aminophenoxy)pentyloxy]- (6CI) |  | C19H24N2O4 | 詳情 | 供應商 | |
| 105639-14-3 | Benzenemethanol,5-(4,5-dihydro-2-oxazolyl)-2-[[5-(3-methyl-5-isoxazolyl)pentyl]oxy]- |  | C19H24N2O4 | 詳情 | 供應商 | |
| 38103-61-6 | Benzamide,4-[2-[[2-hydroxy-3-(2-methylphenoxy)propyl]amino]ethoxy]-; Tolamolol; UK 6558; dl-Tolamolol; dl-UK 6558 |  | C19H24N2O4 | 詳情 | 供應商 | |
| 130783-39-0 | Benzamide,4-[3-[[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]butyl]-; GP 2-114 |  | C19H24N2O4 | 詳情 | 供應商 | |
| 154297-11-7 | Benzamide,4-[(3R)-3-[[(2R)-2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]butyl]-; Benzamide,4-[3-[[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]butyl]-, [R-(R*,R*)]-; GP2-128 |  | C19H24N2O4 | 詳情 | 供應商 | |
| 96681-54-8 | Gelsedine, 14-hydroxy-(9CI); Spiro[3H-indole-3,7'(6'H)-[3,6]methano[1H]oxepino[4,3-b]pyrrole],gelsedine deriv.; 14-Hydroxygelsedine; Dihydrohumantenidine |  | C19H24N2O4 | 詳情 | 供應商 | |
| 306936-27-6 | 1H-Pyrrole-3-carboxylicacid, 1-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]-2-methyl-5-phenyl-; 1-{2-[(TERT-BUTOXYCARBONYL)AMINO]ETHYL}-2-METHYL-5-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID |  | C19H24N2O4 | 詳情 | 供應商 | |
| 15534-05-1 | 1,2-Benzenediol,4-[1-hydroxy-2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-; 1-Piperazineethanol,a-(3,4-dihydroxyphenyl)-4-(o-methoxyphenyl)-(8CI); 711SE; Pipratecol; S 4216 |  | C19H24N2O4 | 詳情 | 供應商 | |
| 10155-49-4 | 2-Naphthalenecarboxamide,3-hydroxy-7-methoxy-N-[3-(4-morpholinyl)propyl]-; 2-Naphthamide,3-hydroxy-7-methoxy-N-(3-morpholinopropyl)- (7CI,8CI) |  | C19H24N2O4 | 詳情 | 供應商 | |
| 64678-02-0 | 5-Pyrimidineaceticacid, 1,6-dihydro-4-methyl-2-[[4-(1-methylethoxy)phenyl]methyl]-6-oxo-, ethylester; 5-Pyrimidineaceticacid, 1,4-dihydro-6-methyl-2-[[4-(1-methylethoxy)phenyl]methyl]-4-oxo-, ethylester (9CI) |  | C19H24N2O4 | 詳情 | 供應商 | |
| 64678-01-9 | 5-Pyrimidineaceticacid, 1,6-dihydro-4-methyl-6-oxo-2-[(4-propoxyphenyl)methyl]-, ethyl ester; 5-Pyrimidineaceticacid, 1,4-dihydro-6-methyl-4-oxo-2-[(4-propoxyphenyl)methyl]-, ethyl ester(9CI) |  | C19H24N2O4 | 詳情 | 供應商 | |
| 67346-49-0 | 福莫特羅 | (R,R)-Formoterol; (R,R)-Formoterol; Formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-; Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, [R-(R*,R*)]-; N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide; 4-[(1R)-2-[[(1R)-2-(4-Methoxyphenyl)-1-methylethyl]amino]-1-hydroxyethyl]-2-(formylamino)phenol; N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(αR)-α-methyl-4-methoxyphenethyl]amino]ethyl]phenyl]formamide; N-[2-Hydroxy-5-[(R)-1-hydroxy-2-[[(R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide; Arformoterol |  | C19H24N2O4 | 詳情 | 供應商 |